pay-for-performance

Pharma

Amgen snags another Enbrel outcomes-based payment deal

Amgen signed a deal with PBM Abarca that ties reimbursement for its RA blockbuster Enbrel to patients' willingness to stick with the drug.
Arlene Weintraub Dec 4, 2019 10:58am

Pfizer 'brainstorming' with payers on gene therapy payment: exec

Nov 8, 2019 10:53am

Boehringer enters Jardiance outcomes-based deal with Prime

Feb 1, 2018 12:07pm

Novartis investors balk at plans to delay Alcon exit

Oct 24, 2017 10:11am

Novartis eyes markets new to performance-based pricing

Oct 5, 2017 12:14pm

Pharma execs wary of value-based contracting: PwC

Sep 22, 2017 10:30am